ZBTB38 inhibitors are a class of chemical compounds designed to specifically target ZBTB38, a transcription factor belonging to the ZBTB (zinc finger and BTB) family of proteins, which play a crucial role in regulating gene expression. ZBTB38 contains two essential domains that define its function: the zinc finger domain, which binds to specific DNA sequences, and the BTB (Broad-Complex, Tramtrack, and Bric-à-Brac) domain, which mediates protein-protein interactions. ZBTB38 is involved in both gene activation and repression, depending on the context, by binding to regulatory regions of DNA and recruiting other proteins such as coactivators or corepressors. The BTB domain facilitates the interaction with other regulatory proteins, often chromatin remodelers or histone modifiers, which help control chromatin structure and gene accessibility. Inhibitors of ZBTB38 disrupt its ability to bind DNA or interfere with its recruitment of essential cofactors, resulting in altered gene expression patterns.
The mechanisms of action of ZBTB38 inhibitors can vary depending on the chemical structure of the compound. One common strategy involves targeting the zinc finger motifs, which are responsible for the protein's DNA-binding activity. Inhibitors may chelate the zinc ions that are necessary to stabilize these motifs, thereby preventing ZBTB38 from interacting with its target DNA sequences. Without proper DNA binding, ZBTB38 cannot regulate the transcription of its target genes. Alternatively, inhibitors can act by disrupting the BTB domain, which is critical for protein-protein interactions required for forming transcriptional regulatory complexes. By inhibiting these interactions, ZBTB38 inhibitors block the protein's ability to recruit coactivators or corepressors, further impairing its role in gene regulation. The study of ZBTB38 inhibitors provides important insights into the broader mechanisms of transcriptional control, highlighting the importance of zinc finger and BTB domain-containing proteins in maintaining the balance of gene expression and cellular function.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
By inhibiting DNA methyltransferase, 5-Azacytidine could decrease methylation on the ZBTB38 promoter, which may lead to a downregulation of ZBTB38 expression through changes in chromatin accessibility. | ||||||
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $214.00 $316.00 $418.00 | 7 | |
5-Aza-2′-Deoxycytidine's inhibition of DNA methylation could lead to a reduction in ZBTB38 expression by altering the transcriptional control of the gene, potentially diminishing its mRNA synthesis. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $130.00 $270.00 | 37 | |
Suberoylanilide Hydroxamic Acid may downregulate ZBTB38 by inhibiting histone deacetylases, resulting in hyperacetylated chromatin that could suppress ZBTB38 gene transcription. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $149.00 $470.00 $620.00 $1199.00 $2090.00 | 33 | |
Trichostatin A could inhibit the transcriptional initiation of ZBTB38 by promoting an open chromatin state, which often leads to transcriptional silencing of certain genes. | ||||||
RG 108 | 48208-26-0 | sc-204235 sc-204235A | 10 mg 50 mg | $128.00 $505.00 | 2 | |
RG 108 could reduce the expression of ZBTB38 by blocking DNA methyltransferase activity, potentially leading to promoter demethylation and subsequent transcriptional silencing. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $30.00 $46.00 $82.00 $218.00 | 19 | |
Sodium Butyrate may lower ZBTB38 expression levels by inhibiting histone deacetylase, which can lead to an increased acetylation state that often correlates with gene silencing. | ||||||
Mithramycin A | 18378-89-7 | sc-200909 | 1 mg | $54.00 | 6 | |
Mithramycin A could decrease ZBTB38 gene transcription by binding to DNA in the promoter region, thereby preventing the assembly of transcriptional machinery. | ||||||
Disulfiram | 97-77-8 | sc-205654 sc-205654A | 50 g 100 g | $52.00 $87.00 | 7 | |
Disulfiram could lead to a decrease in ZBTB38 expression by inhibiting DNA methyltransferase, potentially leading to altered transcription factor binding. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $26.00 $92.00 $120.00 $310.00 $500.00 $908.00 $1821.00 | 46 | |
Genistein may downregulate ZBTB38 by inhibiting DNA methyltransferase, which could cause hypomethylation and repression of the ZBTB38 gene's transcription. | ||||||
Parthenolide | 20554-84-1 | sc-3523 sc-3523A | 50 mg 250 mg | $79.00 $300.00 | 32 | |
Parthenolide may suppress the expression of ZBTB38 by inhibiting the NF-kB pathway, which might be involved in the transcriptional initiation of the ZBTB38 gene. | ||||||